Thermal balloon endometrial ablation (Cavaterm) in the management of menorrhagia

Sadoon, S.; Salman, G. A.; Kirwan, P. H.

doi:10.1080/01443610600984495

Cited by 4 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The treatment of menorrhagia can either be medical therapy, hysterectomy or destruction of the endometrial. Medical therapy is the first-line therapy, but this is not successful while hysterectomy is effective in treatment of bleeding but it is associated with many complications ( 3 , 4 ). In addition, it is often more expensive than medical therapy ( 5 ).…”

Section: Introductionmentioning

confidence: 99%

Thermal Balloon Endometrial Ablation in the Treatment of Heavy Menstrual Bleeding

Bouzari¹,

Yazdani²,

Azimi³

et al. 2014

Med Arh

View full text Add to dashboard Cite

Aim:Heavy menstrual bleeding is one of the common health problems in women. The first-line therapy of heavy menstrual bleeding is the medical therapy, but this is not successful. Currently, global ablation procedures were introduced for treating of heavy menstrual bleeding. The aim of this study was to the analysis of the patient with menorrhagia performed operations of Cavaterm in our university affiliated hospital, and explores its effectiveness and acceptability.Methods:A retrospective study was conducted on 30 patients with menorrhagia who were unresponsive to hormone therapy or not candidates for hysterectomy underwent endometrial ablation using Cavaterm. Preoperative and postoperative PBAC Scoring System was used to assess menorrhagia. Outcome measures were amenorrhea rates, reduction of menstrual flow rates, heavy bleeding, menstrual and patients’ satisfaction rates at 3, 6 and 12 months postoperative.Results:After a follow-up at 3, 6, and 12 months postoperative, 36.7%, 43.3%, and 36.7% of women had a reduction in vaginal bleeding, respectively. Amenorrhea rates were 56.7%, 50.0%, and 56.7% in the Cavaterm at 3, 6, and 12 months. The rate of women’s reported good or excellent satisfaction was 93.3% in 12 months. During the follow-up period, no woman received a subsequent hysterectomy.Conclusion:The findings of this research indicated that outcome with the Cavaterm was as good for women with menorrhagia. Therefore, it is necessary to emphasize on lower operative and post-operative procedural risk and a deleterious effect on patients who were unresponsive to hormone therapy.

show abstract

Section: Introductionmentioning

confidence: 99%